The Knockdown of ACTL6A Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma by Modulating the Wnt/β-Catenin Signaling Pathway. Here, ACTL6A is linked to esophageal squamous cell carcinoma.